BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
Objective: Bevacizumab improved survival when added to chemotherapy for patients with metastatic colorectal cancer (mCRC). The aim of this study was to explore the efficacy and safety of Bevacizumab containing chemotherapy regimen in the treatment of patient with mCRC. Methods: From January 2010 t...
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Peytchinski Publishing
2014-12-01
|
| coleção: | Journal of IMAB |
| Assuntos: | |
| Acesso em linha: | http://www.journal-imab-bg.org/issue-2014/issue6/JofIMAB_2014-20-6p556-559.pdf |